AI assistant
LB PHARMACEUTICALS INC — Director's Dealing 2025
Sep 11, 2025
33183_dirs_2025-09-10_aba20559-1ba3-46c1-b29a-5e6eb06aac81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LB PHARMACEUTICALS INC (LBRX)
CIK: 0001691082
Period of Report: 2025-09-10
Reporting Person: Garland J. Scott (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $41.84 | 2034-03-03 | Common Stock (17929) | Direct | |
| Stock Option (Right to Buy) | $41.84 | 2034-06-05 | Common Stock (3585) | Direct |
Footnotes
F1: One fourth (1/4) of the shares subject to the option award vested on March 4, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F2: One fourth (1/4) of the shares subject to the option award vested on January 31, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.